News & Press: Advocacy News

CCTS Newsletter | July 22, 2020

Wednesday, July 22, 2020  
Posted by: Lauren Stevens
Share |

CCTS Newsletter

Dale Dirks and Dane Christiansen

July 22, 2020

With limited legislative days until the protracted August congressional recess, the House and Senate worked to address critical items. The focus of lawmakers continued to be on a fifth COVID-19 response package with the Senate expected to announce a counter-proposal to the House-passed HEROES Act in the near future. Partisan disagreements over high-profile issues delayed the annual funding bills in the Senate, while the House managed to mark up its appropriations bills. Of specific interest to the clinical and translational research community, the House Fiscal Year (FY) 2021 appropriations measures propose the following allocations for key programs:

  • $47 billion for NIH, $5.5 billion above the FY 2020 enacted level.
    • $3.16 billion for the National Institute of General Medical Sciences, a proposed increase of $244.27 million over FY 2020.
      • $396.57 million for Institutional Development Awards, a proposed increase of $10 million over FY 2020.
    • $365.31 million for the National Institute on Minority Health and Health Disparities, a proposed increase of $29.5 million over FY 2020.
      • $80 million for Research Centers in Minority Institutions, a proposed increase of $5 million over FY 2020.
    • $893.65 million for the National Center for Advancing Translational Sciences, a proposed increase of $60.76 million over FY 2020.
      • “At least” $578.14 million for Clinical and Translational Science Awards, level-funded from FY 2020.
      • “Up to” $60 million for the Cures Acceleration Network, level-funded from FY 2020.
  • $343 million for AHRQ, an increase of $5 million above the FY 2020 enacted level.

Congress is expected to table appropriations efforts until after the November elections before negotiating final spending bills during the “lame duck” session at the end of the year.